23<\/h2>\nPublicacions<\/h2>\n\t\t\t\t![\"Hematopoietic-Stem-Cell-Biology-And-Leukemogenesis\"](\"https:\/\/idibell.cat\/wp-content\/uploads\/2020\/05\/Hematopoietic-Stem-Cell-Biology-And-Leukemogenesis.png\" "\\"Hematopoietic-Stem-Cell-Biology-And-Leukemogenesis\\"")
\n\t\t\t\t\tL\u00ednies estrat\u00e8giques<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\tIdentificar vies de desenvolupament involucrades en la generaci\u00f3 de c\u00e8l\u00b7lules mare hematopo\u00e8tiques per dirigir la diferenciaci\u00f3 de c\u00e8l\u00b7lules mare pluripotencials en c\u00e8l\u00b7lules hematopo\u00e8tiques cl\u00ednicament rellevants<\/p>\n
Desenvolupar models de desenvolupament de c\u00e8l\u00b7lules mare del c\u00e0ncer de sang basats en c\u00e8l\u00b7lules pluripotents indu\u00efdes.<\/p>\n
Aquests objectius es realitzaran combinant gen\u00f2mica, transcript\u00f2mica, edici\u00f3 de gens i t\u00e8cniques biol\u00f2giques cel\u00b7lulars.<\/p>\n\t\t\t\t\tPublicacions seleccionades<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t– Bigas A, Palma LG, Kartha GM, Giorgetti A. Using Pluripotent Stem Cells to Understand Normal and Leukemic Hematopoietic Development<\/strong>. Stem Cells Transl. Med.<\/p>\n– Kotmayer L, Romero Moya D, Marin Bejar O, Kozyra E, Catal\u00e0 A, Bigas A, Wlodarski MW, B\u00f6d\u00f6r C, Giorgetti A. GATA2 deficiency and MDS\/AML: Experimental strategies for disease modelling and future therapeutic prospects.<\/strong> Br J Haematol. 2022;199(4):482-495. doi:10.1111\/bjh.18330.<\/p>\n– Pera J, Casta\u00f1o J, Casamitjana J, Giorgetti A, Romero Moya D. Generation of heterozygous SAMD9 CRISPR\/Cas9-edited iPSC line (ESi086-A-3), carrying p.I1567M mutation<\/strong>. Stem Cell Res. 2022;64102906-102906. doi:10.1016\/j.scr.2022.102906.<\/p>\n– Casta\u00f1o J, Romero Moya D, Richaud Patin Y, Giorgetti A. Generation of two heterozygous GATA2 CRISPR\/Cas9-edited iPSC lines, R398W and R396Q, for modeling GATA2 deficiency<\/strong>. Stem Cell Res. 2021;55102445-102445. doi:10.1016\/j.scr.2021.102445. IF:2,02.<\/p>\n– Maroni G, Bassal MA, Krishnan I, Fhu CW, Savova V, Zilionis R, Maymi VA, Pandell N, Csizmadia E, Zhang JY, Storti B, Castano J, Panella R, Li J, Gustafson CE, Fox S, Levy RD, Meyerovitz CV, Tramontozzi PJ, Vermilya K, De Rienzo A, Crucitta S, Basseres DS, Weetall M, Branstrom A, Giorgetti A, Ciampi R, Del Re M, Danesi R, Bizzarri R, Yang H, Kocher O, Klein AM, Welner RS, Bueno R, Magli MC, Clohessy JG, Ali A, Tenen DG, Levantini E. Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer<\/strong>. Commun Biol. 2021;4(1):370-370. doi:10.1038\/s42003-021-01897-6. IF:6,27.<\/p>\n\t\t\t\t\tProjectes seleccionats<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t\n- FIS23073. Smart Health Community (SHC), promoviendo la medicina basada en el valor. Instituto de Salud Carlos III (ISCIII). Budget: 416.864\u20ac. 2024-2027. PI: Giorgetti, Alessandra.<\/li>\n
- 20DPS001. Human disease modelling of GATA2-related Myelodysplastic Syndromes and Acute Myeloid Leukemia. Generalitat de Catalunya. Budget: 211.882,44\u20ac. 2019-2023. PI: Giorgetti, Alessandra.<\/li>\n
- ERA23004. 3D-GATA2: How GATA2 Deficiency affects development and disease. Instituto de Salud Carlos III (ISCIII). Budget: 180.000\u20ac. 2024-2026. PI: Giorgetti, Alessandra.<\/li>\n
- 21MAR001. New approaches for the identification and functional characterization of prognostic genetic biomarkers in inherited childhood myelodysplastic\/acute leukemia syndromes”. Fundaci\u00f3 La Marat\u00f3 de TV3. Budget: 142.392,18\u20ac. 2021-2024. PI: Giorgetti, Alessandra.<\/li>\n
- INT21042. Die Untersuchung genetischer und mechanistischer Auswirkungen einer Monosomie 7 bei der GATA2 Defizienz (Investigating genetic and mechanistic contributions of monosomy 7 in GATA2 deficiency). DEUTSCHE JOS\u00c9 CARRERAS LEUK\u00c4MIE-STIFTUNG E.V.. Budget: 136.000\u20ac. 2022-2025. PI: Giorgetti, Alessandra.<\/li>\n<\/ul>\n\t\t\t\t
![\"Alessandra-Giorgetti22\"](\"https:\/\/idibell.cat\/wp-content\/uploads\/2022\/10\/Alessandra-Giorgetti22-150x150.jpg\" "\\"Alessandra-Giorgetti22\\"")
\n\n\t\tGiorgetti, Alessandra\n\t<\/h4>\n\n\t\t\n\t\tagiorgetti@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\n\t\tInvestigadors principals\n\t<\/h2>\n\t\t\t\t\n\n\t\tGiorgetti, Alessandra\n\t<\/h4>\n\n\t\t\n\t\tagiorgetti@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\n\t\t ENLLA\u00c7OS RELACIONATS\n\t<\/h4>\n\n\t\t\n\t\t@HeSteCBio\n\t\t<\/a>\n\t<\/h4>\n\n\t\t\n\t\tORCID\n\t\t<\/a>\n\t<\/h4>\n\n\t\t\n\t\tGoogle Scholar\n\t\t<\/a>\n\t<\/h4>\n\n\t\tEquip\n\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\tCap de grup\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadors\/es postdoctorals\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadors\/es predoctorals\t\t\t\t<\/a>\n\t\t\t\t\t\tCap de grup\n\t\t\t\t\t\t\t\t\t\t\t\n- Giorgetti, Alessandra<\/li>\n<\/ul>\n\t\t\t\t\t\tInvestigadors\/es postdoctorals\n\t\t\t\t\t\t\t\t\t\t\t
\n- Romero Moya, Dami\u00e0<\/li>\n<\/ul>\n\t\t\t\t\t\tInvestigadors\/es predoctorals\n\t\t\t\t\t\t\t\t\t\t\t
\n- Pera Garcia, Joan<\/li>\n
- Magallon Mosella, Maria<\/li>\n<\/ul>\n
\n\t\tNot\u00edcies relacionades\n\t<\/h2>\n\t\t\n\t\t\t\t<\/a>\n\t\t\tUn nou estudi identifica una signatura epigen\u00e8tica associada a la defici\u00e8ncia de GATA2, un trastorn gen\u00e8tic rar<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t09\/03\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tComen\u00e7a el programa d’intercanvi entre IDIBELL i SZBL<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t06\/05\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEl grup liderat per la Dra. Alessandra Giorgetti rep una ajuda de la GESMD per estudiar la s\u00edndrome mielodispl\u00e0stica<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t18\/03\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tLa Marat\u00f3 finan\u00e7ar\u00e0 10 projectes de l’IDIBELL en malalties minorit\u00e0ries amb 1,5 milions d’euros<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t30\/11\/2020\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEL P-CMR[C] estrena p\u00e0gina web<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t09\/06\/2020\t\t\t\t\t\t\t\n\t\t\n\n","protected":false},"excerpt":{"rendered":"Biologia de c\u00e8l\u00b7lules mare hematopo\u00e8tiques i leucemog\u00e8nesi Resum Les c\u00e8l\u00b7lules mare hematopo\u00e8tiques (HSC) es consideren la base de l’hematopoesi en adults. Actualment, la majoria d’aquests trastorns hematol\u00f2gics s\u00f3n curables mitjan\u00e7ant el trasplantament de HSC. No obstant aix\u00f2, la disponibilitat limitada de donants compatibles \u00f2ptims segueix sent un repte, especialment per a individus d’origen no cauc\u00e0sic […]<\/p>\n","protected":false},"author":8,"featured_media":0,"parent":3924,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"publishpress_future_action":{"enabled":false,"date":"2024-05-25 20:07:21","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/12815"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=12815"}],"version-history":[{"count":6,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/12815\/revisions"}],"predecessor-version":[{"id":25549,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/12815\/revisions\/25549"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/3924"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=12815"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n\t\t\t\t\tL\u00ednies estrat\u00e8giques<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\tIdentificar vies de desenvolupament involucrades en la generaci\u00f3 de c\u00e8l\u00b7lules mare hematopo\u00e8tiques per dirigir la diferenciaci\u00f3 de c\u00e8l\u00b7lules mare pluripotencials en c\u00e8l\u00b7lules hematopo\u00e8tiques cl\u00ednicament rellevants<\/p>\n
Desenvolupar models de desenvolupament de c\u00e8l\u00b7lules mare del c\u00e0ncer de sang basats en c\u00e8l\u00b7lules pluripotents indu\u00efdes.<\/p>\n
Aquests objectius es realitzaran combinant gen\u00f2mica, transcript\u00f2mica, edici\u00f3 de gens i t\u00e8cniques biol\u00f2giques cel\u00b7lulars.<\/p>\n\t\t\t\t\tPublicacions seleccionades<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t – Bigas A, Palma LG, Kartha GM, Giorgetti A. Using Pluripotent Stem Cells to Understand Normal and Leukemic Hematopoietic Development<\/strong>. Stem Cells Transl. Med.<\/p>\n – Kotmayer L, Romero Moya D, Marin Bejar O, Kozyra E, Catal\u00e0 A, Bigas A, Wlodarski MW, B\u00f6d\u00f6r C, Giorgetti A. GATA2 deficiency and MDS\/AML: Experimental strategies for disease modelling and future therapeutic prospects.<\/strong> Br J Haematol. 2022;199(4):482-495. doi:10.1111\/bjh.18330.<\/p>\n – Pera J, Casta\u00f1o J, Casamitjana J, Giorgetti A, Romero Moya D. Generation of heterozygous SAMD9 CRISPR\/Cas9-edited iPSC line (ESi086-A-3), carrying p.I1567M mutation<\/strong>. Stem Cell Res. 2022;64102906-102906. doi:10.1016\/j.scr.2022.102906.<\/p>\n – Casta\u00f1o J, Romero Moya D, Richaud Patin Y, Giorgetti A. Generation of two heterozygous GATA2 CRISPR\/Cas9-edited iPSC lines, R398W and R396Q, for modeling GATA2 deficiency<\/strong>. Stem Cell Res. 2021;55102445-102445. doi:10.1016\/j.scr.2021.102445. IF:2,02.<\/p>\n – Maroni G, Bassal MA, Krishnan I, Fhu CW, Savova V, Zilionis R, Maymi VA, Pandell N, Csizmadia E, Zhang JY, Storti B, Castano J, Panella R, Li J, Gustafson CE, Fox S, Levy RD, Meyerovitz CV, Tramontozzi PJ, Vermilya K, De Rienzo A, Crucitta S, Basseres DS, Weetall M, Branstrom A, Giorgetti A, Ciampi R, Del Re M, Danesi R, Bizzarri R, Yang H, Kocher O, Klein AM, Welner RS, Bueno R, Magli MC, Clohessy JG, Ali A, Tenen DG, Levantini E. Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer<\/strong>. Commun Biol. 2021;4(1):370-370. doi:10.1038\/s42003-021-01897-6. IF:6,27.<\/p>\n\t\t\t\t\tProjectes seleccionats<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t Biologia de c\u00e8l\u00b7lules mare hematopo\u00e8tiques i leucemog\u00e8nesi Resum Les c\u00e8l\u00b7lules mare hematopo\u00e8tiques (HSC) es consideren la base de l’hematopoesi en adults. Actualment, la majoria d’aquests trastorns hematol\u00f2gics s\u00f3n curables mitjan\u00e7ant el trasplantament de HSC. No obstant aix\u00f2, la disponibilitat limitada de donants compatibles \u00f2ptims segueix sent un repte, especialment per a individus d’origen no cauc\u00e0sic […]<\/p>\n","protected":false},"author":8,"featured_media":0,"parent":3924,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"publishpress_future_action":{"enabled":false,"date":"2024-05-25 20:07:21","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/12815"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=12815"}],"version-history":[{"count":6,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/12815\/revisions"}],"predecessor-version":[{"id":25549,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/12815\/revisions\/25549"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/3924"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=12815"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\n
\n\n\t\tGiorgetti, Alessandra\n\t<\/h4>\n
\n\t\t\n\t\tagiorgetti@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tInvestigadors principals\n\t<\/h2>\n\t\t\t\t
\n\n\t\tGiorgetti, Alessandra\n\t<\/h4>\n
\n\t\t\n\t\tagiorgetti@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n
\n\t\t ENLLA\u00c7OS RELACIONATS\n\t<\/h4>\n
\n\t\t\n\t\t@HeSteCBio\n\t\t<\/a>\n\t<\/h4>\n
\n\t\t\n\t\tORCID\n\t\t<\/a>\n\t<\/h4>\n
\n\t\t\n\t\tGoogle Scholar\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tEquip\n\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\tCap de grup\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadors\/es postdoctorals\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadors\/es predoctorals\t\t\t\t<\/a>\n\t\t\t\t\t\tCap de grup\n\t\t\t\t\t\t\t\t\t\t\t
\n
\n
\n
\n\t\tNot\u00edcies relacionades\n\t<\/h2>\n\t\t\n\t\t\t\t<\/a>\n\t\t\tUn nou estudi identifica una signatura epigen\u00e8tica associada a la defici\u00e8ncia de GATA2, un trastorn gen\u00e8tic rar<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t09\/03\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tComen\u00e7a el programa d’intercanvi entre IDIBELL i SZBL<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t06\/05\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEl grup liderat per la Dra. Alessandra Giorgetti rep una ajuda de la GESMD per estudiar la s\u00edndrome mielodispl\u00e0stica<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t18\/03\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tLa Marat\u00f3 finan\u00e7ar\u00e0 10 projectes de l’IDIBELL en malalties minorit\u00e0ries amb 1,5 milions d’euros<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t30\/11\/2020\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEL P-CMR[C] estrena p\u00e0gina web<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t09\/06\/2020\t\t\t\t\t\t\t\n\t\t\n\n","protected":false},"excerpt":{"rendered":"